Inflammatory disease management poses challenges due to the complexity of inflammation
and inherent patient variability, thereby necessitating patient-specific therapeutic …

Autoimmune diseases are chronic, destructive diseases that can cause functional disability
and multiple organ failure. Despite significant advances in the range of therapeutic agents …

Critical advances have recently been made in the field of immunotherapy, contributing to an
improved understanding of how to harness and balance the power of immune responses in …

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by synovitis and
damage of cartilage and bone. Many efforts have been made in the past to develop …

Macrophages are cells of the innate immune system that are resident in all tissues, including
metabolic organs such as the liver and adipose tissue (AT). Because of their phenotypic …

Macrophages are one of the most abundant non‐malignant cells in the tumor
microenvironment, playing critical roles in mediating tumor immunity. As important innate …

There have been many recent exciting developments in biomimetic nanoparticles for
biomedical applications. Inflammation, a protective response involving immune cells, blood …

The progression of osteoarthritis is associated with chronic synovitis caused by synovial
macrophage infiltration and proinflammatory M1 polarization. Accordingly, repolarization of …

Acute respiratory distress syndrome (ARDS) has been a life threat for patients in ICUs. Vast
efforts have been devoted, while no medication has proved viable, which may be ascribed to …

Nanomaterials exhibit significant potential for stimulating immune responses, offering both
local and systemic modulation across a variety of diseases. The lymphoid organs, such as …